- Home
- CLPT vs PRME Comparison
CLPT vs PRME Comparison
Compare CLPT & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPT
- PRME
- Stock Information
- Founded
- CLPT 1998
- PRME 2019
- Country
- CLPT United States
- PRME United States
- Employees
- CLPT N/A
- PRME N/A
- Industry
- CLPT Medical/Dental Instruments
- PRME Medicinal Chemicals and Botanical Products
- Sector
- CLPT Health Care
- PRME Health Care
- Exchange
- CLPT Nasdaq
- PRME Nasdaq
- Market Cap
- CLPT 355.7M
- PRME 424.9M
- IPO Year
- CLPT N/A
- PRME 2022
- Fundamental
- Price
- CLPT $12.14
- PRME $4.09
- Analyst Decision
- CLPT Strong Buy
- PRME Strong Buy
- Analyst Count
- CLPT 2
- PRME 8
- Target Price
- CLPT $12.00
- PRME $14.14
- AVG Volume (30 Days)
- CLPT 237.3K
- PRME 964.4K
- Earning Date
- CLPT 11-07-2024
- PRME 11-12-2024
- Dividend Yield
- CLPT N/A
- PRME N/A
- EPS Growth
- CLPT N/A
- PRME N/A
- EPS
- CLPT N/A
- PRME N/A
- Revenue
- CLPT $28,069,000.00
- PRME $591,000.00
- Revenue This Year
- CLPT $33.39
- PRME N/A
- Revenue Next Year
- CLPT $24.44
- PRME N/A
- P/E Ratio
- CLPT N/A
- PRME N/A
- Revenue Growth
- CLPT 29.33
- PRME N/A
- 52 Week Low
- CLPT $4.05
- PRME $3.28
- 52 Week High
- CLPT $14.13
- PRME $9.86
- Technical
- Relative Strength Index (RSI)
- CLPT 41.22
- PRME 51.81
- Support Level
- CLPT $12.39
- PRME $3.85
- Resistance Level
- CLPT $13.86
- PRME $4.20
- Average True Range (ATR)
- CLPT 0.87
- PRME 0.28
- MACD
- CLPT -0.10
- PRME -0.00
- Stochastic Oscillator
- CLPT 33.57
- PRME 37.88
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, and ClearPoint Therapeutic Solutions.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.